// App-Quantinova.ai

2802 : Sustained Remission of Inflammation Is Associated with Reduced Structural Damage on SI Joint MRI in Patients with Early Axial Spa: Evidence to Support the Concept of Treat-to-Target

Researchers

Presenter

  • Walter P. Maksymowych

Principal Investigators

  • Pascal Claudepierre

  • Manouk de Hooge

  • Robert G. Lambert

  • Robert B.M. Landew

  • Anna Molto

  • Dsire van der Heijde

  • Jack F Bukowski

  • Heather Jones

  • Isabelle Logeart

  • Lisa Marshall

  • Ronald Pedersen

  • Annette Szumski

  • Bonnie Vlahos

  • Maxime Dougados

Medical Centers

  • Radiology & Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada

  • Universite Paris Est, Creteil, France

  • Leiden University Medical Centre, Leiden, Netherlands

  • Radiology & Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada

  • Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands

  • Clinical Affairs, Pfizer, Collegeville, PA

  • Inflammation & Immunology Global Medical Affairs, Pfizer, Collegeville, PA

  • Medical Affairs, Pfizer, France, Paris, France

  • Department of Biostatistics, Pfizer, Collegeville, PA

  • Biostatistics, inVentiv Health, Princeton, NJ

  • Clinical Affairs, Pfizer, Collegeville, PA

  • Hospital Cochin, Descartes Univ, Paris, France

Locations

  • Canada

  • France

  • Netherlands

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • Malondialdehyde

Drug/Treatment

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • Placebo Control

  • Double Blind/Blinded

  • Open Label

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved